AI for Geographic Atrophy

Book free trial to see how AI can detect GA and 70+ other pathologies/biomarkers

Book Intro

AI for geographic atrophy (GA) detection on OCT is the most objective and accurate method of GA analysis today. Altris AI offers:

Detect biomarkers of GA: RPE atrophy, Neurosensory retina atrophy, EZ disruption, RPE disruption, and others.
Measure the area and volume of each GA biomarker.
Precisely calculate the GA area by measuring the overlap of Hypertransmission, RPE atrophy, and Neurosensory retina atrophy.
Progression analysis: monitor the results of the GA treatment over time.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA-cleared (510k).

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Make informed decisions based on objective insights.
Leverage the power of the most precise GA detection.

Advanced AI for GA with three overlapping biomarkers: hypertransmission, RPE atrophy, and neurosensory retinal atrophy.

Precise GA Area Calculation: the area where biomarkers overlap is measured to determine the true size of GA.

Spatial Analysis: how far GA is from the fovea and how much of the macula it covers.

Progression Analysis: tracking changes in the area of the three-biomarker overlap and all pathological changes on scans over time.

How Altris AI works?

And what's the value of using Artificial intelligence for Geographic Atrophy

Altris AI is a web platform created by retina experts for all eye care specialists and clinicians.
We’ve collected millions of OCT scans with various pathologies to train the AI algorithm.

Automatically prioritize scans based on the presence and extent of pathology.
Detect over 70 pathologies and signs, including GA biomarkers: hypertransmission, RPE disruption and atrophy, EZ disruption, and more.
Measure and track pathological changes across multiple examinations.
Create customizable reports to enhance communication and facilitate informed decision-making.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Clinical Research

What you get with Altris AI:

Accelerate ophthalmic drug trial with AI
Detect GA and its biomarkers ( +70 retinal pathologies and biomarkers) with AI
Track the progression of biomarkers to assess drug efficiency
Enroll the right patients based on fast biomarkers detection
Reduce costs associated with manual scan review with automated analysis
Reduce human made errors to the minimum

For Eye Care

We support you through the whole way

14 Days of Free Trial to see the value
Support during the whole trial period
Early glaucoma assessment module access
CE-certified, GDPR, HIPAA compliant, FDA clearance
Integration support with any EHR, EMR system.
Access to the whole functional during trial